Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Contacts
Similar Companies347
20/20 HealthCare Partners
20/20 HealthCare Partners invests in early-stage healthcare technology and life science innovation.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
WFD Ventures
WFD Ventures is a New York-based venture capital firm specialized in investing in medical device and healthcare technology companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Latterell Venture Partners
Latterell Venture Partners is a venture capital firm specialized in startups and early stage healthcare companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Catalyst Health Ventures
Catalyst Health Ventures is a Boston-based venture capital firm that invests in disruptive solutions for unmet healthcare needs.
Sector
Subsector
Location
count Of Investments
count Of Exists
Financials
Investments17
Tasso
Tasso is changing the way diagnostics are delivered with a safe and convenient blood collection device.
Sector
Subsector
Keywords
Location
total rounds
total raised
Neuros Medical
Neuros Medical is a neuromodulation company that develops neurostimulation therapies for patients with unmet medical needs..
Sector
Subsector
Location
total rounds
total raised
Metagenomi
Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.
Sector
Subsector
Location
total rounds
total raised
Co-Investors
Exits2
BodyMedia
BodyMedia develops wearable on-body monitoring systems to improve health, wellness, and fitness.
Sector
Subsector
Keywords
Location
total rounds
total raised
Spinal Modulation
Spinal Modulation is a medical device company that develops spinal cord neurostimulator systems for chronic intractable pain.
Sector
Subsector
Location
total rounds
total raised
People
Founders2
Andrew Farquharson
Andrew is an investor and entrepreneur with two decades of experience building, restructuring and acquiring companies in life sciences. A founding member of InCube's venture fund, Andrew is also an advisor to InCube Labs, LLC, which develops breakthrough medical technologies under the leadership of Mir Imran. Prior to joining InCube, Andrew served as a Partner in the Halo Funds, where he completed a Kauffman Fellowship and led investments in a portfolio of life science firms. These investments include Intrapace (obesity), Penumbra (ischemic stroke), Sonoma Orthopedic Products (bone repair), SwitchGear Genomics (gene regulation) & Spinal Modulation (pain management). Andrew has also been an active angel investor in a broader variety of ventures. Earlier in his career, Andrew served as Executive Vice President of sales, marketing and research for Operon Technologies. During his tenure there, Andrew built a global sales force from scratch, grew revenues of synthetic DNA products to $40M in two years, and helped to negotiate a sale of the business to QIAGEN for $150M. He subsequently acquired a company in Japan for QIAGEN, and restructured it into the company's global operations. Prior to Operon, Andrew held several roles in research operations at Genentech, Inc., where he managed $200M of protein therapeutic production and optimized cell lines for expression. Andrew has also co-founded a gene design business in agricultural biotechnology (Glucazyme), launched a company in microfludics (Innovadyne), sat on a wide range of boards, and developed strategies for healthcare firms as a consultant with Deloitte & Touche.
current job
Andrew Farquharson